Blend: BPC-157 TB-500 Peptide (20MG)
0What is the difference between BPC-157 and TB-500?
BPC-157 is a gastric-derived peptide that supports vascular and soft-tissue systems. TB-500 is a synthetic version of Thymosin Beta-4 that regulates cell movement and structure. BPC-157 focuses on vascular systems, while TB-500 drives cellular and structural systems.
Frequently Asked Questions
What is the difference between BPC-157 and TB-500?
BPC-157 is a gastric-derived peptide that supports vascular and soft-tissue systems. TB-500 is a synthetic version of Thymosin Beta-4 that regulates cell movement and structure. BPC-157 focuses on vascular systems, while TB-500 drives cellular and structural systems.
What are the safety profiles of BPC-157 and TB-500?
In multiple animal and in-vitro studies, both peptides have demonstrated high tolerability and absence of systemic toxicity. BPC-157 showed no adverse effects even under prolonged exposure. Similarly, systemic TB-500 administration in rats, dogs, and primates was well tolerated up to 60 mg/kg intravenously, with no histopathological abnormalities reported.